0001144204-17-021384.txt : 20170420
0001144204-17-021384.hdr.sgml : 20170420
20170420211728
ACCESSION NUMBER: 0001144204-17-021384
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170419
FILED AS OF DATE: 20170420
DATE AS OF CHANGE: 20170420
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PLx Pharma Inc.
CENTRAL INDEX KEY: 0001497504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271707962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8285 EL RIO STREET
STREET 2: SUITE 130
CITY: HOUSTON
STATE: TX
ZIP: 77054
BUSINESS PHONE: (713) 842-1249
MAIL ADDRESS:
STREET 1: 8285 EL RIO STREET
STREET 2: SUITE 130
CITY: HOUSTON
STATE: TX
ZIP: 77054
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20140313
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20100726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valentino Michael J
CENTRAL INDEX KEY: 0001319551
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36351
FILM NUMBER: 17774031
MAIL ADDRESS:
STREET 1: 8285 EL RIO STREET
STREET 2: SUITE 130
CITY: HOUSTON
STATE: TX
ZIP: 77054
4
1
v464782_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-04-19
0
0001497504
PLx Pharma Inc.
PLXP
0001319551
Valentino Michael J
8285 EL RIO STREET
SUITE 130
HOUSTON
TX
77054
1
1
0
0
Executive Chairman
Common Stock
2017-04-19
4
A
0
93295
A
93295
D
Options
12.44
2017-04-19
4
A
0
112509
0
A
2025-07-22
Common Stock
112509
112509
D
Received in exchange for 118,461 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the "Merger") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.).
Received in connection with the Merger in exchange for an employee stock option to buy 142,857 shares of PLx Opco Inc. common stock for $9.80 per share.
The option is exercisable as to 60,005 shares as of the date hereof, and will become exercisable as to an additional 26,252 shares on each of July 22, 2017 and July 22, 2018 (generally subject to continued employment or consulting relationship through such date).
/s/ David E. Jorden, David E. Jorden, as Attorney-in-Fact for Michael J. Valentino
2017-04-20